Skip to main content
. Author manuscript; available in PMC: 2025 Jul 31.
Published in final edited form as: Liver Transpl. 2024 Mar 13;30(8):848–861. doi: 10.1097/LVT.0000000000000362

Table 4.

Post-transplant Alcohol Relapse Risk Scores

Risk Score Author Study
Design,
Population
Outcome Score Components AUC*
ARRA Rodrigue et al., 201364 Single-center, retrospective, chronic ALD Any alcohol use Absence of HCC, tobacco dependence, continued alcohol use after liver disease diagnosis, low motivation for alcohol treatment, poor stress management skills, no rehabilitation relationship, limited social support, lack of nonmedical behavioral consequences, and continued engagement in social activities with alcohol present. 0.89
BIS-11 SF Umman et al., 202372 Single-center, retrospective
Alcohol-associated liver failure
Any alcohol use Questions that assess motor impulsiveness 0.83
HALT Satapathy et al., 202069 Single-center, retrospective, chronic ALD and AH Harmful alcohol use (> 3 drinks per week or medical/social harm) Older age at LT, non-alcohol-related criminal history, pre-LT abstinence period < 6 months, > 10 drinks per day. 0.79
HRAR DiMartini et al., 200068 Single-center, retrospective, chronic ALD Any alcohol use daily alcohol consumption, drinking duration, previous alcohol treatment history Not predictive
Penn Psychosocial Model Deutsch-Link, et al., 202057 Single-center, retrospective, chronic ALD Any alcohol use Failure to engage in an IOP despite clinician recommendation, history of relapse after initial attempt at sobriety, did not stop alcohol consumption when diagnosed with liver disease 0.77
SALT Lee et al., 201870 Multi-center, retrospective Sustained alcohol use with > 100 days of use >10 drinks per day at initial hospitalization, multiple prior rehabilitation attempts, prior alcohol-related legal issues, and prior illicit substance use 0.76
SIPAT Deutsch-Link, et al., 202057 Single-center, retrospective, chronic ALD Any alcohol use SIPAT score ≥21 0.71

Abbreviations: AH, alcohol-associated hepatitis; ALD, alcohol-associated liver disease; ARRA, Alcohol Relapse Risk Assessment Scale; BIS-11 SF, Barratt Impulsiveness Scale-11 Short Form, HALT - HCC – hepatocellular carcinoma, IOP – intensive outpatient program, HRAR - High-Risk Alcoholism Relapse, SALT - Sustained Alcohol Use Post-Liver Transplant, SIPAT-Stanford Integrated Psychosocial Assessment for Transplant

*

95% CI was not uniformly provided in the reviewed publications and has not been reported.